Nelson C - Search Results

1

Acute disruption of cytochrome oxidase activity in brain in a perinatal rat stroke model.

Nelson C, Silverstein FS. Nelson C, et al. Pediatr Res. 1994 Jul;36(1 Pt 1):12-9. doi: 10.1203/00006450-199407001-00003. Pediatr Res. 1994. PMID: 7936831

2

The microsomal calcium-ATPase inhibitor thapsigargin is a neurotoxin in perinatal rodent brain.

Silverstein FS, Nelson C. Silverstein FS, et al. Among authors: nelson c. Neurosci Lett. 1992 Oct 12;145(2):157-60. doi: 10.1016/0304-3940(92)90010-5. Neurosci Lett. 1992. PMID: 1465212 Free article.

3

Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.

Bigge CF, Malone TC, Boxer PA, Nelson CB, Ortwine DF, Schelkun RM, Retz DM, Lescosky LJ, Borosky SA, Vartanian MG, et al. Bigge CF, et al. Among authors: nelson cb. J Med Chem. 1995 Sep 15;38(19):3720-40. doi: 10.1021/jm00019a003. J Med Chem. 1995. PMID: 7562904

4

The association of diabetic status, age, and race to withdrawal from dialysis.

Nelson CB, Port FK, Wolfe RA, Guire KE. Nelson CB, et al. J Am Soc Nephrol. 1994 Feb;4(8):1608-14. doi: 10.1681/ASN.V481608. J Am Soc Nephrol. 1994. PMID: 8025234

5

Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s.

Nelson CB, Port FK, Wolfe RA, Guire KE. Nelson CB, et al. J Am Soc Nephrol. 1992 Nov;3(5):1147-55. doi: 10.1681/ASN.V351147. J Am Soc Nephrol. 1992. PMID: 1482753

6

Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonist.

Corbin AE, Pugsley TA, Akunne HC, Whetzel SZ, Zoski KT, Georgic LM, Nelson CB, Wright JL, Wise LD, Heffner TG. Corbin AE, et al. Among authors: nelson cb. Pharmacol Biochem Behav. 1998 Feb;59(2):487-93. doi: 10.1016/s0091-3057(97)00442-5. Pharmacol Biochem Behav. 1998. PMID: 9476999

7

Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.

Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC. Tecle H, et al. Among authors: nelson cb. J Med Chem. 1998 Jul 2;41(14):2524-36. doi: 10.1021/jm960683m. J Med Chem. 1998. PMID: 9651157

8

Identification and characterization of m4 selective muscarinic antagonists.

Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD. Augelli-Szafran CE, et al. Among authors: nelson cb. Bioorg Med Chem Lett. 1998 Aug 4;8(15):1991-6. doi: 10.1016/s0960-894x(98)00351-5. Bioorg Med Chem Lett. 1998. PMID: 9873472

9

Design and synthesis of novel quinoxaline-2,3-dione AMPA/GlyN receptor antagonists: amino acid derivatives.

Nikam SS, Cordon JJ, Ortwine DF, Heimbach TH, Blackburn AC, Vartanian MG, Nelson CB, Schwarz RD, Boxer PA, Rafferty MF. Nikam SS, et al. Among authors: nelson cb. J Med Chem. 1999 Jun 17;42(12):2266-71. doi: 10.1021/jm980455n. J Med Chem. 1999. PMID: 10377233

10

Identification and characterization of m1 selective muscarinic receptor antagonists1.

Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ. Augelli-Szafran CE, et al. Among authors: nelson cb. J Med Chem. 1999 Feb 11;42(3):356-63. doi: 10.1021/jm980067l. J Med Chem. 1999. PMID: 9986705

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,176 results

Search Page

Filters